Status | Study |
Not yet recruiting |
Study Name: Checkpoint Inhibitors Assessment in Oropharynx Carcinoma (CIAO) Condition: Malignant Neoplasms of Lip Oral Cavity and Pharynx Date: 2017-05-05 Interventions: Drug: Durvalumab 20 mg/Kg by v |
Recruiting |
Study Name: Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers Condition: Malignant Neoplasms of Lip Oral Cavity and Pharynx Head and Nec Date: 2017-04-11 Interventions: Behavioral: Yoga Participants |
Recruiting |
Study Name: Atezolizumab and Bevacizumab in Rare Solid Tumors Condition: Malignant Neoplasms of Digestive Organs Malignant Neoplasms of Lip Date: 2017-02-22 Interventions: Drug: Atezolizumab 1200 mg by |
Recruiting |
Study Name: The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor Condition: Oral Cancer Date: 2017-01-09 Interventions: Radiation: Radiotherapy Radiot |
Recruiting |
Study Name: Modeling Adherence to Preventive Swallowing Exercises in Head and Neck Cancer Condition: Malignant Neoplasms of Lip Oral Cavity and Pharynx Head and Nec Date: 2017-01-03 Interventions: Behavioral: Questionnaire |
Not yet recruiting |
Study Name: Lenvatinib and Capecitabine in Patients With Advanced Malignancies Condition: Advanced Cancer Malignant Neoplasm of Breast Malignant Neo Date: 2016-09-23 Interventions: Drug: Lenvatinib |
Recruiting |
Study Name: Validation of DNA Methylation Biomarkers for Oral Cancer Detection-Follow up Study Condition: Oral Cancer Date: 2016-09-12 |
Recruiting |
Study Name: HOUSTON - HPV-related Oropharyngeal and Uncommon Cancers Screening Trial Of Men Condition: Malignant Neoplasms of Digestive Organs Malignant Neoplasms of Lip Date: 2016-09-07 Interventions: Procedure: Oropharyngeal Cancer Screening |
Withdrawn |
Study Name: Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies Condition: Malignant Neoplasms of Digestive Organs Malignant Neoplasms of Female Genital Organs Date: 2016-06-16 Interventions: Drug: Alisertib |
Recruiting |
Study Name: Oral State of Patients Affected by an Oral Cancer Before and After Radiotherapy - 3-years Prospective Study Condition: Oral Cancer Date: 2015-01-06 Interventions: Behavioral: Quality of life survey/ dental statement Assessment of oral state and patients quality of li |